REG - Centrica PLC - Director/PDMR Shareholding

CentricaAnnouncement

17/05/2024 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240517:nRSQ9777Oa&default-theme=true

RNS Number : 9777O  Centrica PLC  17 May 2024

Centrica plc (the "Company")

17 May 2024

Notification of Transactions of Directors

The Company announces that it was notified on 17 May 2024 of the following
transactions in respect of the Company's Ordinary Shares of 6(14/81) pence
("Shares").

The following notification, made pursuant to Article 19 of the Market Abuse
Regulation, provides further details.

Vesting of Award - Long Term Incentive Plan

Awards granted under Centrica plc's Long Term Incentive Plan ("LTIP") on 17
May 2021 vested today, 17 May 2024.

As reported in the Company's 2022 Annual Report and Accounts, the vesting of
the award was subject to the satisfaction of performance conditions assessed
over the three-year period from 1 January 2020 to 31 December 2022. The
vesting outcome was 76% of the original award.

Following the sale of Shares to cover statutory withholding liabilities, the
remaining Shares will be held for a mandatory two-year holding period.

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name(s)                                  Chris O'Shea
 2   Reason for the notification
 a)  Position/status                          Executive Director
 b)  Initial notification/Amendment           Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     Centrica plc
 b)  LEI                                      E26EDV109X6EEPBKVH76
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial             Ordinary Shares of 6(14/81) pence

     instrument, type of instrument

     Identification code

                                              GB00B033F229
 b)  Nature of the transaction                Vesting on 17 May 2024 of nil cost conditional award granted on 17 May 2021
                                              under the LTIP and subsequent sale of Shares to cover statutory withholding
                                              liabilities. The remaining Shares are subject to a mandatory two-year holding
                                              period.
 c)  Price(s) and volume(s)                   Number of Shares vested  Number of Shares sold to cover statutory withholding liabilities  Number of Shares retained  Sale Price (£)
                                              2,785,622                1,329,135                                                         1,456,487                  £1.438679
 d)  Aggregated information

     -        Aggregated volume               As in 4(c) above.

     -        Price                           As in 4(c) above.

 e)  Date of the transaction                  17 May 2024
 f)  Place of the transaction                 London Stock Exchange (XLON)

d)

Aggregated information

 

-        Aggregated volume

-        Price

 

 

 

As in 4(c) above.

As in 4(c) above.

 

e)

Date of the transaction

17 May 2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGPUBWAUPCGAM